{"filing":{"accession_number":"0001568651-26-000066","cik":"0001568651","ticker":"OSCR","company_name":"Oscar Health, Inc.","form":"8-K","filing_date":"2026-08-06","report_date":"2026-08-06","primary_document":"oscr-20260806.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1568651/000156865126000066/oscr-20260806.htm"},"events":[{"id":25817,"run_id":23437,"accession_number":"0001568651-26-000066","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Oscar Health announced its financial results for Q2 2026 and raised full-year 2026 guidance on August 6, 2026. The disclosure includes detailed quarterly and six-month financial statements showing record profitability (net income of $361.8M vs. loss of $228.4M in Q2 2025), improved medical loss ratio (79.2% vs. 91.1%), and raised earnings from operations guidance ($500M–$700M vs. prior $250M–$450M). This is a standard earnings release with attached press release and financial statements, typical of Item 2.02 disclosures.","company_name":"Oscar Health, Inc.","ticker":"OSCR","filing_date":"2026-08-06","form":"8-K","submitted_at":null,"items":[{"id":26741,"accession_number":"0001568651-26-000066","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Oscar Health announced its financial results for Q2 2026 and raised full-year 2026 guidance on August 6, 2026. The disclosure includes detailed quarterly and six-month financial statements showing record profitability (net income of $361.8M vs. loss of $228.4M in Q2 2025), improved medical loss ratio (79.2% vs. 91.1%), and raised earnings from operations guidance ($500M–$700M vs. prior $250M–$450M). This is a standard earnings release with attached press release and financial statements, typical of Item 2.02 disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:35:57.670561+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":26741,"accession_number":"0001568651-26-000066","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Oscar Health announced its financial results for Q2 2026 and raised full-year 2026 guidance on August 6, 2026. The disclosure includes detailed quarterly and six-month financial statements showing record profitability (net income of $361.8M vs. loss of $228.4M in Q2 2025), improved medical loss ratio (79.2% vs. 91.1%), and raised earnings from operations guidance ($500M–$700M vs. prior $250M–$450M). This is a standard earnings release with attached press release and financial statements, typical of Item 2.02 disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-09T02:35:57.670561+00:00","company_name":"Oscar Health, Inc.","ticker":"OSCR","filing_date":"2026-08-06"}]}